無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

スマートピル・ドラッグデリバリー市場 - 成長、傾向、および予測(2019年 - 2024年)

Smart Pills Drug Delivery Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 390696
出版日 ページ情報 英文 115 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.74円で換算しております。
Back to Top
スマートピル・ドラッグデリバリー市場 - 成長、傾向、および予測(2019年 - 2024年) Smart Pills Drug Delivery Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年06月01日 ページ情報: 英文 115 Pages
概要

世界のスマートピル・ドラッグデリバリー市場は、2019年から2024年の間に11.50%のCAGRで成長すると予測されています。市場の成長要因には、低侵襲性装置の選好増加、胃腸障害の発生率の増加、および技術の進歩などが挙げられます。

当レポートは世界のスマートピル・ドラッグデリバリー市場について調査し、市場の動向や機会、成長および阻害要因、タイプ・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • 調査の成果
  • 調査の仮定
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 低侵襲性装置に対する選択の増大
    • 消化器疾患の発生率の増加
    • 技術の進歩
  • 市場阻害要因
    • スマートピル承認のための厳格な規制
    • 潜在的な健康リスク
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • タイプ別
    • カプセル内視鏡
    • 患者モニタリング
    • ドラッグおよびデリバリーシステム
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • CapsoVision
    • Check-Cap
    • etectRx Inc.
    • HQ Inc.
    • Jinshan Science and Technology
    • Koninklijke Philips NV (Medimetrics)
    • Medtronic PLC
    • オリンパス株式会社
    • 大塚製薬株式会社
    • Proteus Pharmaceuticals
    • Intromedic

第7章 市場機会および将来動向

目次
Product Code: 51919

Market Overview

Global Smart Pills Drug Delivery market is expected to witness a CAGR of 11.50% during the forecast period. Certain factors that are driving the market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements.

There are various technological advancements in smart pills in recent years. For instance, Novartis partnered with Proteus and developed a sensory enabled smart pill, which once swallowed can gather the information that can be used to diagnose patients. In addition, Australian researchers developed an electronic capsule, which is designed to analyze the composition of the gas in the small and large intestine and send the data to an external device in 5-minute intervals. In 2018, the researchers revealed that they used a wireless capsule equipped with sensors, battery, and a radio transmitter for monitoring the production of gas in the human digestive tract. The pill can also detect the levels of oxygen, hydrogen, and carbon dioxide. Due to the advancement of these technologies, patients are likely to adopt these smart pills for more efficient care and treatment, which is expected to augment the growth of the market.

Scope of the Report

Smart pills are the capsules that are prescribed to patients and are equipped with the electronic sensors, which send a wireless message to devices, like patches, tablets or smartphones outside the body when they are ingested.

Key Market Trends

Capsule Endoscopy is Expected to Hold Significant Market Share in the Type Segment

With the advents in healthcare technology, smart pills are capable of eliminating the need for invasive procedures. The wireless communication of smart pills allows understanding of the real-time information. Various advances are being undertaken in the smart pills, such as advances in batteries and on-board memory, which are making them significant for long-term usage. It is expected that smart pills will become an integral part of remote patient monitoring and telemedicine. National Institute of Health has stated that the advancements in capsule endoscopy are being done rapidly, and in the near future, with an interface application, doctors will be able to control the movement of the device, inside the body. Through this technique, they can easily inspect or diagnose the point of the area, in the body. Hence, with the continuous advancements that are being done in the area of endoscopy, and with the rising need for proper diagnosis of the gastrointestinal disorders, it is believed that the market studied will have a rapid growth, over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

There are about 1.6 million Americans that are found to have inflammatory bowel diseases (IBD). This includes about 780,000 people with Crohn's disease and another 907,000 people with ulcerative colitis. Researchers have estimated that there are 6 to 15 new cases of Crohn's disease that are diagnosed per 100,000 people, each year. Therefore, the increasing prevalence of gastrointestinal disorders is anticipated to fuel the market, over the forecast period. There is also vast research being conducted, for instance, the US researchers have developed an ingestible capsule that can be controlled wirelessly, to deliver drugs. The scientists from the Massachusetts Institute of Technology and Brigham and Women's Hospital developed a capsule that can be customized to deliver drugs and can sense environmental conditions. 3-D printing technology is being used to manufacture these capsules, which could be used to treat various diseases. These smart capsules could also be designed to sense infections, allergic reactions, or other events, and then release a drug in response. Hence, all these factors contribute to the increasing research that will be responsible for driving the overall market.

Competitive Landscape

The global Smart Pills Drug Delivery market is highly competitive and consists of a few major players. Companies like CapsoVision, Check-Cap, etectRx Inc., HQ Inc., Jinshan Science and Technology, Koninklijke Philips NV (Medimetrics), Medtronic PLC, Olympus Medical Technology, Otsuka Pharmaceutical Co. Ltd, Proteus Pharmaceuticals, and Intromedic, among others, hold the substantial market share in the Smart Pills Drug Delivery market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Minimally Invasive Devices
    • 4.2.2 Increasing Incidence of Gastrointestinal Disorders
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulations for the Approval of Smart Pills
    • 4.3.2 Potential Health Risk
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Capsule Endoscopy
    • 5.1.2 Patient Monitoring
    • 5.1.3 Drug and Delivery Systems
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 US
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 UK
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 CapsoVision
    • 6.1.2 Check-Cap
    • 6.1.3 etectRx Inc.
    • 6.1.4 HQ Inc.
    • 6.1.5 Jinshan Science and Technology
    • 6.1.6 Koninklijke Philips NV (Medimetrics)
    • 6.1.7 Medtronic PLC
    • 6.1.8 Olympus Medical Technology
    • 6.1.9 Otsuka Pharmaceutical Co. Ltd
    • 6.1.10 Proteus Pharmaceuticals
    • 6.1.11 Intromedic

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top